denkapparat Operations GmbH
Position in SUPN — Supernus Pharmaceuticals, Inc.
CIK 1999514
BERLIN, 2M
Position in SUPN
as of Jun 30, 2026
· filed Aug 6, 2026
Position Value
$288,455
-$32,126 QoQ
Shares Held
6,202
0.0% QoQ
Ownership
0.011%
of shares outstanding
% of Portfolio
0.09%
of 13F equity value
Holder Rank
#210
of 331 holders
Holding Since
Mar 2025
5 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in SUPN Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026denkapparat Operations GmbH holds $4,057,072 across 6 Drug Manufacturers - Specialty & Generic names. SUPN ranks #5 (7.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | NBIX |
Neurocrine Biosciences Inc
|
7,188 | $1,211,465 | |
| 2 | LNTH |
Lantheus Holdings, Inc.
|
9,416 | $1,044,611 | |
| 3 | UTHR |
UNITED THERAPEUTICS Corp
|
1,582 | $857,175 | |
| 4 | INDV |
Indivior Pharmaceuticals, Inc.
|
11,074 | $454,366 | |
| 5 | SUPN |
Supernus Pharmaceuticals, Inc.
This page
|
6,202 | $288,455 | |
| 6 | BCRX |
Biocryst Pharmaceuticals Inc
|
20,100 | $201,000 |
All Filings in SUPN
Export CSV
5 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $288,455 | 6,202 | Shares | Sole | 2026-08-06 | |
| 2026-03-31 | $320,581 | 6,202 | Shares | Sole | 2026-05-11 | |
| 2025-12-31 | $308,239 | 6,202 | Shares | Sole | 2026-02-12 | |
| 2025-09-30 | $296,393 | 6,202 | Shares | Sole | 2025-11-07 | |
| 2025-03-31 | $203,115 | 6,202 | Shares | Sole | 2025-05-08 | |
| No filing history on record for this holder in this stock. | ||||||